SARAH CANNON

Sarah Cannon

SARAH CANNON - Sarah Cannon

2004
$25 to $50 million (USD)
501 to 1000+ Employees
CEO Sarah Cannon

CEO: Dee Anna Smith

Sarah Cannon, the global cancer enterprise of Hospital Corporation of America (HCA Healthcare), offers integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in communities across the United States and United Kingdom. Through its services, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, Sarah Cannon is redefining cancer care around the world.

Keyword Suggest For Search

sarah cannon research institute

sarah cannon research

sarah cannon research institute uk

sarah cannon research medical center

sarah cannon research uk

sarah cannon research institute nashville tn

sarah cannon research jobs

sarah cannon research kcmo

sarah cannon research center

sarah cannon research institute address

sarah cannon research institute llc

sarah cannon research institute jobs

Website sarahcannonresearch.com Information

Internal Links On sarahcannonresearch.com Website

1. sarahcannonresearch.com

sarahcannonresearch.com


2. www.sarahcannonresearch.com

www.sarahcannonresearch.com


3. Sarah Cannon

Daiichi Sankyo and Sarah Cannon Research Institute announced that the first patient has been dosed in the first-in-human phase 1 study evaluating DS-6000, a CDH6 directed antibody drug conjugate (ADC), in patients with advanced renal cell carcinoma or ovarian cancer with disease progression following standard treatment.


Other Businesses

Search on Google Search

Loading